{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:04:18Z","timestamp":1767978258317,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/hco.0b013e3283589572","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T07:31:06Z","timestamp":1349163066000},"page":"669-674","source":"Crossref","is-referenced-by-count":8,"title":["Impact of in-hospital major bleeding on outcomes in acute coronary syndromes"],"prefix":"10.1097","volume":"27","author":[{"given":"Sharon S.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Sergie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210204","first-page":"e2","article-title":"Heart disease and stroke statistics2012 update: a report from the American Heart Association.","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"R2-17-20210204","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1161\/CIR.0b013e318212bb8b","article-title":"2011 ACCFAHA Focused Update Incorporated Into the ACCAHA 2007 Guidelines for the Management of Patients With Unstable AnginaNon-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines.","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"R3-17-20210204","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2011.12.045","article-title":"Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry.","volume":"59","author":"Subherwal","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R4-17-20210204","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIbIIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"R5-17-20210204","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jacc.2011.07.021","article-title":"Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.","volume":"58","author":"Suh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R6-17-20210204","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/eurheartj\/ehs012","article-title":"The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction.","volume":"33","author":"Lopes","year":"2012","journal-title":"Eur Heart J"},{"key":"R7-17-20210204","first-page":"361","article-title":"What is the optimal antithrombotic strategy in primary percutaneous coronary intervention Curr Opin C","volume":"27","author":"Sergie","year":"2012","journal-title":"ardiol"},{"key":"R8-17-20210204","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction.","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"R9-17-20210204","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R10-17-20210204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ahj.2010.11.021","article-title":"Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes.","volume":"161","author":"Jolly","year":"2011","journal-title":"Am Heart J"},{"key":"R11-17-20210204","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ahj.2009.10.034","article-title":"Hematomas of at least 5cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.","volume":"159","author":"White","year":"2010","journal-title":"Am Heart J"},{"key":"R12-17-20210204","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcin.2011.08.018","article-title":"Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dellEmilia-Romagna) multicenter registry.","volume":"5","author":"Valgimigli","year":"2012","journal-title":"JACC Cardiovasc Intervent"},{"key":"R13-17-20210204","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcin.2010.10.011","article-title":"Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention.","volume":"4","author":"Verheugt","year":"2011","journal-title":"JACC Cardiovasc Intervent"},{"key":"R14-17-20210204","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.amjcard.2011.11.007","article-title":"Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention.","volume":"109","author":"Joyal","year":"2012","journal-title":"Am J Cardiol"},{"key":"R15-17-20210204","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.amjcard.2011.11.019","article-title":"Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapy.","volume":"109","author":"Mehta","year":"2012","journal-title":"Am J Cardiol"},{"key":"R16-17-20210204","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCINTERVENTIONS.111.961912","article-title":"Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.","volume":"4","author":"Bangalore","year":"2011","journal-title":"Circ Cardiovasc Intervent"},{"key":"R17-17-20210204","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction C","volume":"116","author":"Spencer","year":"2007","journal-title":"irculation"},{"key":"R18-17-20210204","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes.","volume":"307","author":"De Berardis","year":"2012","journal-title":"JAMA"},{"key":"R19-17-20210204","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1537-2995.2002.00148.x","article-title":"Improved maintenance of 2,3 diphosphoglycerate (DPG) and adenosine triphosphate (ATP) in red blood cells (RBCs) stored in a modified additive solution.","volume":"42","author":"Hogman","year":"2002","journal-title":"Transfusion"},{"key":"R20-17-20210204","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1161\/CIRCULATIONAHA.108.787143","article-title":"Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.","volume":"118","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"R21-17-20210204","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","article-title":"Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.","volume":"4","author":"Mehran","year":"2011","journal-title":"JACC Cardiovasc Intervent"},{"key":"R22-17-20210204","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can apid Risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACCAHA Guidelines) bleeding score.","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"R23-17-20210204","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archinternmed.2012.2449","article-title":"Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation outcome of patients who refuse transfusion.","volume":"172","author":"Pattakos","year":"2012","journal-title":"Arch Intern Med"},{"key":"R24-17-20210204","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/jama.2010.708","article-title":"Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.","volume":"303","author":"Marso","year":"2010","journal-title":"JAMA"},{"key":"R25-17-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2012.02.039","article-title":"Bleeding-avoidance strategies and outcomes in patients =80 Yea80 Years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry).","volume":"110","author":"Dodson","year":"2012","journal-title":"Am J Cardiol"},{"key":"R26-17-20210204","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jcin.2010.08.015","article-title":"Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry - GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines).","volume":"3","author":"Kadakia","year":"2010","journal-title":"JACC Cardiovasc Intervent"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e3283589572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:53:59Z","timestamp":1620953639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201211000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283589572","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}